Does gram-negative bacteremia require a transesophageal echocardiogram (TEE) in the presence of a pacemaker?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gram-Negative Bacteremia with Pacemaker: TEE Not Routinely Required

In patients with gram-negative bacteremia and a pacemaker, transesophageal echocardiography (TEE) is not routinely indicated unless there are specific high-risk features suggesting infective endocarditis (IE), as gram-negative organisms rarely cause secondary device infection through hematogenous seeding.

Risk Stratification Based on Organism Type

Gram-Negative vs. Gram-Positive Bacteremia

  • Gram-negative bacteremia with cardiac devices carries dramatically lower risk of device infection compared to Staphylococcus aureus bacteremia 1
  • In patients with pacemakers/ICDs and gram-negative bacteremia, only 6% develop definite or possible device infection, compared to 45% with S. aureus bacteremia 1
  • Hematogenous seeding of pacemaker systems by gram-negative organisms appears to be exceptionally rare or nonexistent 1
  • When gram-negative device infection does occur, it typically involves obvious generator pocket infection rather than lead vegetations 1

Relapse Risk with Device Retention

  • Among patients with gram-negative bacteremia who retained their devices and survived initial infection, relapsing bacteremia occurred in only 6% over median follow-up of 759 days 1
  • The rare relapses observed had alternative sources identified, not the cardiac device 1
  • This contrasts sharply with gram-positive organisms, particularly S. aureus, where device retention carries substantial relapse risk 1

When TEE Is Indicated in Bacteremia Patients

High-Risk Clinical Features Requiring TEE

According to American Heart Association guidelines, TEE should be performed when clinical suspicion of IE remains high despite negative or nondiagnostic TTE 2:

  • Prosthetic heart valves (not just the pacemaker itself) 2
  • New atrioventricular block or conduction abnormalities suggesting perivalvular extension 2
  • Persistent fever despite appropriate antibiotics (>72 hours) 3, 4
  • New valvular regurgitation or heart failure 2
  • Embolic phenomena suggesting vegetation 2

Initial Imaging Approach

  • Start with transthoracic echocardiography (TTE) in all suspected IE cases, as it is the recommended first-line test 2, 5
  • TTE has reasonable sensitivity (60-70%) for native valve endocarditis but only 25-40% sensitivity for device-related infections 6
  • Proceed to TEE if TTE is negative but clinical suspicion remains high, or if TTE is positive but complications need assessment 2

Specific Algorithm for Gram-Negative Bacteremia with Pacemaker

Step 1: Assess for Alternative Source

  • If clear alternative source identified (urinary tract, biliary, gastrointestinal, pulmonary), device infection is highly unlikely 1
  • Examine generator pocket for erythema, warmth, fluctuance, or purulent drainage 1

Step 2: Risk Stratification

Proceed to TTE if any of the following present 2, 5:

  • No identifiable source of bacteremia
  • Generator pocket signs of infection
  • New heart murmur
  • Embolic phenomena
  • Persistent fever >72 hours on appropriate antibiotics
  • New conduction abnormalities on ECG

Step 3: TEE Decision After TTE

Proceed to TEE only if 2, 6:

  • TTE is nondiagnostic or technically limited
  • TTE shows vegetations and need to assess for complications (abscess, perforation)
  • High clinical suspicion persists despite negative TTE with risk factors above
  • TEE sensitivity for device infections is approximately 90% compared to 25-40% for TTE 6

Step 4: If TEE Initially Negative

  • Repeat TEE in 3-5 days if clinical suspicion persists, as early vegetations may be too small or abscesses may appear only as nonspecific thickening initially 2, 7

Critical Distinctions from Staphylococcus aureus

Why S. aureus Guidelines Don't Apply

  • For S. aureus bacteremia, TEE is reasonable (Class IIa) even without obvious IE features due to 25% IE rate 5, 3, 8
  • S. aureus bacteremia with pacemakers shows 32-fold increased risk of IE in multivariate analysis 3
  • TEE is essential in S. aureus bacteremia because sensitivity of TTE is only 32% versus 100% for TEE 8

Gram-Negative Organism Behavior

  • Gram-negative organisms demonstrate fundamentally different pathophysiology, rarely adhering to cardiac devices or valves through hematogenous spread 1
  • When device infection occurs with gram-negative organisms, it is typically from direct inoculation at implantation or pocket manipulation, not secondary seeding 1

Common Pitfalls to Avoid

  • Do not reflexively order TEE for all bacteremia patients with pacemakers—organism type matters critically 1
  • Do not assume negative TTE rules out IE in high-risk scenarios—TEE sensitivity is >90% versus 60-70% for TTE 6, 7
  • Do not delay appropriate antibiotics while awaiting echocardiography 2
  • Do not forget to examine the generator pocket physically—this is where gram-negative device infections manifest 1
  • If TEE is performed and negative but suspicion remains, repeat in 3-5 days rather than accepting single negative study 2, 7

Quality of Life and Mortality Considerations

  • Intracardiac abscess detected on echocardiography independently predicts both in-hospital and 1-year mortality 7
  • Death due to sepsis is significantly more likely in IE patients (15%) versus uncomplicated bacteremia (3%) 8
  • Unnecessary TEE carries procedural risks (though bacteremia risk from TEE itself is negligible at 0%) 9
  • The key mortality benefit comes from identifying the minority of patients who truly have IE and require prolonged antibiotics or surgical intervention, not from routine screening of low-risk populations 8, 1

References

Research

Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Infective Endocarditis in Patients with Post-Obstructive Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Accuracy of Transesophageal Echocardiography for Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Echocardiography Strategy for Candidemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.